Legend Biotech (LEGN) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $1.0 billion.
- Legend Biotech's Retained Earnings fell 939.43% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 939.43%. This contributed to the annual value of $1.0 billion for FY2024, which is 1684.81% down from last year.
- Latest data reveals that Legend Biotech reported Retained Earnings of $1.0 billion as of Q3 2025, which was down 939.43% from $1.0 billion recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Retained Earnings ranged from a high of $1.4 billion in Q2 2023 and a low of $206424.0 during Q1 2021
- Its 5-year average for Retained Earnings is $849.8 million, with a median of $1.0 billion in 2025.
- Its Retained Earnings has fluctuated over the past 5 years, first surged by 35893238.0% in 2022, then plummeted by 1762.83% in 2024.
- Legend Biotech's Retained Earnings (Quarter) stood at $766.0 million in 2021, then decreased by 2.87% to $744.0 million in 2022, then soared by 68.19% to $1.3 billion in 2023, then dropped by 16.85% to $1.0 billion in 2024, then dropped by 2.81% to $1.0 billion in 2025.
- Its Retained Earnings was $1.0 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.0 billion in Q1 2025.